AMPX RSI Chart
Last 7 days
-30.5%
Last 30 days
-20.8%
Last 90 days
-65.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 10.7M | 0 | 0 | 0 |
2023 | 3.0M | 3.9M | 5.9M | 9.1M |
2022 | 3.6M | 4.3M | 4.8M | 4.4M |
2021 | 0 | 4.0M | 3.4M | 2.8M |
2020 | 0 | 0 | 0 | 4.7M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 12, 2024 | bornstein jonathan | acquired | 50,393 | 0.05 | 1,007,870 | president of amprius lab |
Apr 02, 2024 | bornstein jonathan | acquired | 6,299 | 0.05 | 125,983 | president of amprius lab |
Apr 02, 2024 | bornstein jonathan | sold | -299,613 | 2.3782 | -125,983 | president of amprius lab |
Mar 19, 2024 | sun kang | acquired | - | - | 1,419,670 | see remarks |
Mar 19, 2024 | stefan constantin ionel | acquired | - | - | 374,570 | chief technology officer |
Mar 19, 2024 | bornstein jonathan | acquired | - | - | 558,930 | president of amprius lab |
Mar 19, 2024 | wallach sandra | acquired | - | - | 749,700 | chief financial officer |
Mar 06, 2024 | bornstein jonathan | sold | -111,579 | 2.7756 | -40,200 | president of amprius lab |
Mar 06, 2024 | bornstein jonathan | acquired | 2,010 | 0.05 | 40,200 | president of amprius lab |
Mar 05, 2024 | bornstein jonathan | sold | -320,462 | 2.9186 | -109,800 | president of amprius lab |
Which funds bought or sold AMPX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -29.44 | -3,078 | 1,683 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -19.63 | -88,201 | 59,448 | -% |
May 16, 2024 | B. Riley Wealth Advisors, Inc. | reduced | -22.66 | -25,622 | 57,828 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | new | - | 11,025 | 11,025 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 318 | 79,132 | 151,161 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -71.66 | -41,867 | 6,928 | -% |
May 15, 2024 | MORGAN STANLEY | added | 3.77 | -228,051 | 246,896 | -% |
May 15, 2024 | STATE STREET CORP | unchanged | - | -347,661 | 348,979 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -36.84 | -29,841 | 13,812 | -% |
May 15, 2024 | LMR Partners LLP | added | 332 | 183,394 | 286,978 | -% |
Unveiling Amprius Technologies, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Amprius Technologies, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
CARR | 58.8B | 23.0B | 43.8 | 2.55 | ||||
HUBB | 21.1B | 5.5B | 29.05 | 3.84 | ||||
BLDR | 20.4B | 17.1B | 13.91 | 1.19 | ||||
CSL | 19.9B | 4.9B | 23.21 | 4.06 | ||||
LECO | 12.9B | - | 23.62 | 3.13 | ||||
MID-CAP | ||||||||
AYI | 8.0B | 3.9B | 21.17 | 2.08 | ||||
AAON | 6.2B | 1.2B | 34.26 | 5.29 | ||||
ATKR | 5.5B | 3.4B | 8.95 | 1.64 | ||||
AEIS | 4.0B | 1.6B | 30.83 | 2.54 | ||||
PLUG | 2.4B | 801.3M | -1.65 | 3 | ||||
SMALL-CAP | ||||||||
APOG | 1.5B | 1.4B | 14.78 | 1.04 | ||||
ACTG | 538.1M | 141.5M | 9.37 | 3.8 | ||||
ACCO | 493.5M | 1.8B | -20.23 | 0.28 | ||||
FCEL | 366.0M | 103.0M | -4 | 3.55 | ||||
APT | 56.3M | 60.9M | 13.37 | 0.92 |
Amprius Technologies, Inc. News
Income Statement (Quarterly) | ||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Revenue | -40.8% | 2,336,000 | 3,944,000 | 2,798,000 | 1,632,000 | 679,000 | 792,000 | 816,000 | 691,000 | 2,110,000 | 1,216,000 | 330,000 | - | - |
Cost Of Revenue | -13.8% | 6,781,000 | 7,869,000 | 7,046,000 | 4,664,000 | 4,104,000 | 2,502,000 | 2,326,000 | 2,055,000 | 3,149,000 | - | 1,986,000 | - | - |
Gross Profit | -13.2% | -4,445,000 | -3,925,000 | -4,248,000 | -3,032,000 | -3,425,000 | -1,710,000 | -1,510,000 | -1,364,000 | -1,039,000 | -895,000 | -1,656,000 | - | - |
Operating Expenses | 0.9% | 5,874,000 | 5,819,000 | 4,883,000 | 7,051,000 | 6,326,000 | 4,937,000 | 2,813,000 | 2,797,000 | 1,871,000 | 2,808,000 | 1,481,000 | - | - |
S&GA Expenses | -5.2% | 4,293,000 | 4,529,000 | 4,068,000 | 6,279,000 | 5,526,000 | 4,248,000 | 2,323,000 | 2,319,000 | 1,502,000 | 2,336,000 | 1,154,000 | 35,924 | - |
R&D Expenses | 22.6% | 1,581,000 | 1,290,000 | 815,000 | 772,000 | 800,000 | 689,000 | 490,000 | 478,000 | 369,000 | 472,000 | 327,000 | - | - |
Net Income | -1.6% | -9,886,000 | -9,734,000 | -8,492,000 | -9,448,000 | -9,102,000 | -6,056,000 | -4,244,000 | -4,154,000 | -2,878,000 | -305,104 | -3,141,000 | -10,102 | - |
Net Income Margin | 13.7% | -3.51 | -4.06 | -5.61 | -7.36 | -7.91 | -3.93 | -2.40 | -2.41 | -1.78 | -3.57 | -2.18 | -1.83 | -1.59 |
Free Cashflow | -29.6% | -13,675,000 | -10,551,000 | -17,609,000 | -7,311,000 | -7,632,000 | -6,432,000 | -3,245,000 | -2,609,000 | -3,077,000 | -2,042,000 | -1,637,000 | - | - |
Balance Sheet | ||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2020Q4 |
Assets | -2.8% | 105 | 108 | 87.00 | 87.00 | 84.00 | 83.00 | 87.00 | 18.00 | 233 | 19.00 | - |
Current Assets | -9.7% | 46.00 | 51.00 | 61.00 | 71.00 | 70.00 | 75.00 | 78.00 | 8.00 | 3.00 | 14.00 | 1.00 |
Cash Equivalents | -11.9% | 40.00 | 46.00 | 53.00 | 65.00 | 64.00 | 70.00 | 74.00 | 5.00 | 9.00 | 11.00 | 0.00 |
Inventory | 17.5% | 1.00 | 1.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | - | 1.00 | 1.00 |
Net PPE | 5.4% | 23.00 | 22.00 | 17.00 | 7.00 | 5.00 | 4.00 | 4.00 | 4.00 | - | 4.00 | 5.00 |
Liabilities | -6.6% | 45.00 | 48.00 | 21.00 | 20.00 | 17.00 | 10.00 | 11.00 | 9.00 | 24.00 | 5.00 | 5.00 |
Current Liabilities | -27.5% | 10.00 | 13.00 | 14.00 | 12.00 | 9.00 | 7.00 | 6.00 | 6.00 | 0.00 | 4.00 | 4.00 |
Shareholder's Equity | 0.2% | 60.00 | 60.00 | 66.00 | 67.00 | 67.00 | 73.00 | 76.00 | 9.00 | 12.00 | 14.00 | 1.00 |
Retained Earnings | -7.6% | -139 | -129 | -119 | -111 | -102 | -92.89 | -86.83 | -82.59 | -21.04 | -75.40 | -65.50 |
Additional Paid-In Capital | 5.3% | 199 | 189 | 186 | 178 | 169 | 166 | 163 | 91.00 | - | 89.00 | 67.00 |
Shares Outstanding | 3.1% | 92.00 | 89.00 | 85.00 | 85.00 | 85.00 | 85.00 | 69.00 | 66.00 | 66.00 | 66.00 | 66.00 |
Float | - | - | - | - | 121 | - | - | - | 184 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Cashflow From Operations | -103.7% | -9,779 | -4,800 | -8,678 | -5,583 | -6,492 | -5,698 | -2,692 | -2,449 | -3,043 | -1,709 | -1,619 | - | - |
Share Based Compensation | 11.8% | 1,247 | 1,115 | 1,115 | 924 | 726 | 586 | 777 | 890 | 456 | 1,771 | 323 | - | - |
Cashflow From Investing | 32.3% | -3,896 | -5,751 | -8,931 | -1,728 | -1,140 | -734 | -553 | -160 | -34.00 | -333 | -18.00 | - | - |
Cashflow From Financing | 179.8% | 8,159 | 2,916 | 5,995 | 8,134 | 2,123 | 2,048 | 71,805 | -431 | 204 | 419 | 14,697 | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 2,336 | $ 679 |
Cost of revenue | 6,781 | 4,196 |
Gross loss | (4,445) | (3,517) |
Operating expenses: | ||
Research and development | 1,581 | 800 |
Selling, general and administrative | 4,293 | 5,434 |
Total operating expenses | 5,874 | 6,234 |
Loss from operations | (10,319) | (9,751) |
Other income | 433 | 649 |
Net loss | $ (9,886) | $ (9,102) |
Weighted-average common shares outstanding: | ||
Weighted-average common shares outstanding, basic (in shares) | 90,029,320 | 84,645,097 |
Weighted-average common shares outstanding, diluted (in shares) | 90,029,320 | 84,645,097 |
Net loss per share of common stock: | ||
Net loss per share of common stock, basic (in dollars per share) | $ (0.11) | $ (0.11) |
Net loss per share of common stock, diluted (in dollars per share) | $ (0.11) | $ (0.11) |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 39,045 | $ 45,761 |
Accounts receivable | 1,442 | 1,265 |
Inventories | 858 | 730 |
Deferred costs | 927 | 779 |
Prepaid expenses and other current assets | 3,351 | 1,987 |
Total current assets | 45,623 | 50,522 |
Non-current assets: | ||
Property, plant and equipment, net | 22,938 | 21,760 |
Operating lease right-of-use assets, net | 34,660 | 35,149 |
Other assets | 1,466 | 305 |
Total assets | 104,687 | 107,736 |
Current liabilities: | ||
Accounts payable | 1,992 | 3,341 |
Accrued and other current liabilities | 3,431 | 5,594 |
Deferred revenue | 3,243 | 3,434 |
Operating lease liabilities | 1,096 | 1,088 |
Total current liabilities | 9,762 | 13,457 |
Non-current liabilities: | ||
Operating lease liabilities | 34,990 | 34,479 |
Total liabilities | 44,752 | 47,936 |
Commitments and contingencies (Note 10) | ||
Stockholders’ equity: | ||
Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding | 0 | 0 |
Common stock; $0.0001 par value; 950,000,000 shares authorized; 92,274,165 and 88,869,463 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 9 | 9 |
Additional paid-in capital | 199,475 | 189,454 |
Accumulated deficit | (139,549) | (129,663) |
Total stockholders’ equity | 59,935 | 59,800 |
Total liabilities and stockholders’ equity | $ 104,687 | $ 107,736 |